Mosquito-Borne Infections Testing Market Growth and Trends

The global Mosquito-Borne Infections Testing Market is witnessing steady growth, driven by the increasing prevalence of mosquito-borne diseases, rising awareness regarding early diagnosis, and growing investments in healthcare infrastructure and disease surveillance programs. According to the latest report by Straits Research, the market was valued at USD 2.80 billion in 2025 and is projected to grow from USD 3.00 billion in 2026 to USD 5.50 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period (2026–2034).

Mosquito-borne infection testing involves diagnostic procedures used to detect diseases such as dengue, malaria, Zika virus, chikungunya, yellow fever, and West Nile virus. These tests include molecular diagnostics, serology-based assays, and rapid diagnostic kits designed for early and accurate disease detection. The increasing frequency of outbreaks and growing public health concerns are significantly contributing to market expansion.

Market Dynamics

Rising Incidence of Mosquito-Borne Diseases Driving Market Growth

The increasing prevalence of mosquito-borne infections worldwide is a key factor driving the market. Climate change, urbanization, population growth, and increased international travel are contributing to the spread of mosquito-borne diseases across regions.

Leading companies such as Abbott Laboratories, Thermo Fisher Scientific, and Roche Diagnostics are developing advanced diagnostic solutions to improve disease detection and outbreak management.

Growing Demand for Rapid and Accurate Diagnostic Solutions Enhancing Market Expansion

Healthcare providers and public health agencies are increasingly adopting rapid and reliable diagnostic tools to enable timely treatment and reduce disease transmission. Advancements in molecular diagnostics and point-of-care testing are further supporting market growth.

Companies such as Bio-Rad Laboratories and Qiagen N.V. are focusing on innovative testing technologies to enhance diagnostic accuracy and efficiency.

Download Free Sample

https://straitsresearch.com/report/mosquito-borne-infections-testing-market/request-sample

Market Segmentation

Comprehensive Segmentation Based on Test Type, Infection Type, and End-User

The mosquito-borne infections testing market is segmented across multiple dimensions, providing insights into its diverse applications. With over 10,624 segmentation categories, the market reflects extensive industry coverage.

Wide Applications Across Dengue, Malaria, and Zika Virus Testing

By test type, the market includes molecular diagnostics, serological tests, and rapid diagnostic tests, with molecular diagnostics holding a significant share due to their high sensitivity and accuracy.

Based on infection type, the market is categorized into dengue, malaria, chikungunya, Zika virus, and other mosquito-borne diseases, with dengue testing accounting for a major share due to increasing global outbreaks.

By end-user, the market includes hospitals, diagnostic laboratories, research institutes, and public health agencies, with hospitals and diagnostic laboratories dominating the market.

Regional Analysis

North America Leading the Market with Advanced Diagnostic Infrastructure

North America holds a significant share in the mosquito-borne infections testing market due to advanced healthcare infrastructure, strong disease surveillance systems, and increasing awareness regarding infectious disease management.

Europe Witnessing Steady Growth with Rising Public Health Initiatives

Europe is experiencing steady growth driven by growing investments in infectious disease monitoring and advancements in diagnostic technologies.

Asia-Pacific Emerging as the Fastest Growing Region

Asia-Pacific is expected to witness the fastest growth during the forecast period, driven by high prevalence of mosquito-borne diseases, expanding healthcare infrastructure, and increasing government initiatives for disease prevention. Companies such as InBios International Inc. and DiaSorin S.p.A. are strengthening their presence in the region.

Latin America and Middle East & Africa Showing Gradual Growth

These regions are gradually expanding due to increasing awareness regarding infectious diseases and rising demand for diagnostic testing solutions.

Competitive Landscape

The global mosquito-borne infections testing market is highly competitive, with key players focusing on product innovation, strategic partnerships, and expansion strategies. Prominent companies operating in the market include Abbott Laboratories, Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad Laboratories, Siemens Healthineers, Quest Diagnostics, Danaher Corporation, NovaTec Immundiagnostica GmbH, InBios International Inc., Euroimmun AG, DiaSorin S.p.A., Qiagen N.V., PerkinElmer Inc., OraSure Technologies, Hologic Inc., and Becton Dickinson.

These companies are investing in research and development to improve testing accuracy, expand diagnostic portfolios, and strengthen their global market presence.

Key Trends and Opportunities

Increasing Adoption of Point-of-Care and Rapid Diagnostic Tests

Rapid diagnostic technologies are improving access to timely disease detection and treatment.

Growing Investments in Infectious Disease Surveillance Programs

Governments and healthcare organizations are increasing investments in disease monitoring and outbreak prevention.

Advancements in Molecular and Multiplex Diagnostic Technologies

Innovative molecular testing platforms are enabling simultaneous detection of multiple mosquito-borne infections.

Conclusion

The global mosquito-borne infections testing market is poised for steady growth, driven by increasing prevalence of vector-borne diseases, rising demand for accurate diagnostic solutions, and expanding public health initiatives. With a projected market size of USD 5.50 billion by 2034 and a CAGR of 7%, the market presents significant opportunities for innovation and expansion across the global healthcare and diagnostics industry.